BMO Capital Initiates Coverage On Integra Lifesciences with Market Perform Rating, Announces Price Target of $19

Benzinga Newsdesk www.benzinga.com Positive 56.0%

Neg 0% Neu 0% Pos 56%

BMO Capital analyst Vik Chopra initiates coverage on Integra Lifesciences (NASDAQ:IART) with a Market Perform rating and announces Price Target of $19.